Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 3(65), 2021
DOI: 10.1128/aac.02254-20
Links
Tools
Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens
Journal article published in 2021 by
T. Nguyen,
M. Oualha 
,
C. Briand,
M. Bendavid,
A. Béranger,
A. Ranger,
S. Benaboud,
J. M. Luyer,
J.-M. Tréluyer,
Y. Zheng,
F. Foissac,
S. Winter,
I. Gana,
S. Boujaafar,
V. Lopez
and other authors.
,
C. Briand,
M. Bendavid,
A. Béranger,
A. Ranger,
S. Benaboud,
J. M. Luyer,
J.-M. Tréluyer,
Y. Zheng,
F. Foissac,
S. Winter,
I. Gana,
S. Boujaafar,
V. Lopez
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Ganciclovir is indicated for curative or preventive treatment of cytomegalovirus (CMV) infections. This study aimed to characterize ganciclovir pharmacokinetics, following intravenous ganciclovir and oral valganciclovir administration, to optimize dosing schemes.